bioXXmed AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	0	0	1	5	6	18
Market Cap Growth	-64.72%	-95.56%	-86.90%	-9.91%	-69.02%	-70.98%
Enterprise Value	0	0	1	4	2	18
Last Close Price	0.77	0.11	6.55	41.01	45.52	185.86
Forward PE	-	14.72	14.72	14.72	14.72	14.72
PS Ratio	12.51	1.79	192.67	295.19	466.16	412.49
PB Ratio	-209336.00	-29905.00	2.11	10.93	0.27	1.03
P/TBV Ratio	-	-	2.11	10.93	0.27	1.03
EV/Sales Ratio	23.35	5.25	167.63	233.04	165.61	394.46
Debt / Equity Ratio	-385000.00	-385000.00	-	0.02	-	0.01
Net Debt / Equity Ratio	-181332.00	-181332.00	-0.80	-1.29	-0.09	0.01
Net Debt / EBITDA Ratio	-0.67	-0.67	0.29	0.75	2.25	-0.08
Net Debt / FCF Ratio	-0.54	-0.54	0.28	0.83	2.01	-
Asset Turnover	0.04	0.04	0.01	0.00	0.00	0.00
Quick Ratio	234.64	234.64	3.15	6.60	13.83	0.16
Current Ratio	356.12	356.12	4.04	7.36	14.23	0.38
Return on Equity (ROE)	-229.36%	-229.36%	-252.84%	-191.41%	-4.23%	-20.40%
Return on Assets (ROA)	-35.44%	-35.44%	-93.01%	-4.52%	-2.58%	-4.84%
Return on Capital Employed (ROCE)	-57.90%	-57.90%	-214.30%	-136.40%	-3.80%	-8.70%
Earnings Yield	-174.55%	-1221.84%	-148.13%	-407.77%	-14.55%	-22.05%
FCF Yield	-	-1120.21%	-136.11%	-14.21%	-16.03%	-
Buyback Yield / Dilution	-	0.00%	-164.59%	-	-27.54%	-